Miroslav Šulc
- Molecular Biology top 10%
- Pharmacology top 1%
- Pharmacology top 5%
- Plant Science top 10%
- Oncology
- Co-authors
- Marie StiborováTomáš ObšilJan TeisingerVeronika ObšilováPetr HeřmanJaroslav VečeřEva FreiPetr Hodek
- Topics
- Pharmacogenetics and Drug Metabolism (24 papers)Microbial Natural Products and Biosynthesis (10 papers)14-3-3 protein interactions (10 papers)
- Cited by
- PharmacologyAgingPhysiology
- Partner nations
- CzechiaGermanyUnited Kingdom
In The Last Decade
Miroslav Šulc
106 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 112
- Molecular Biology 1.2k
- Pharmacology 280
- Pharmacology 222
- Plant Science 193
- Oncology 177
Countries citing papers authored by Miroslav Šulc
This map shows the geographic impact of Miroslav Šulc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miroslav Šulc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miroslav Šulc more than expected).
Fields of papers citing papers by Miroslav Šulc
This network shows the impact of papers produced by Miroslav Šulc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miroslav Šulc. The network helps show where Miroslav Šulc may publish in the future.
Co-authorship network of co-authors of Miroslav Šulc
This figure shows the co-authorship network connecting the top 25 collaborators of Miroslav Šulc. A scholar is included among the top collaborators of Miroslav Šulc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miroslav Šulc. Miroslav Šulc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 8 | |
| 4 | 23 | |
| 5 | 17 | |
| 6 | 12 | |
| 7 | 23 | |
| 8 | 20 | |
| 9 | 14 | |
| 10 | 34 | |
| 11 | 36 | |
| 12 | 3 | |
| 13 | 6 | |
| 14 | 4 | |
| 15 | 2 | |
| 16 | 27 | |
| 17 | 54 | |
| 18 | 23 | |
| 19 | 5 | |
| 20 | 17 |
About Miroslav Šulc
Miroslav Šulc is a scholar working on Pharmacology, Biochemistry and Physiology, having authored 109 papers that have together received 2.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (24 papers), Microbial Natural Products and Biosynthesis (10 papers) and 14-3-3 protein interactions (10 papers). The work is most often cited by research in Pharmacology (280 citations), Aging (50 citations) and Physiology (103 citations). Miroslav Šulc has collaborated with scholars based in Czechia, Germany and United Kingdom. Frequent co-authors include Marie Stiborová, Tomáš Obšil, Jan Teisinger, Veronika Obšilová, Petr Heřman, Jaroslav Večeř, Eva Frei, Petr Hodek, Evžen Bouřa and Jan Šilhán. Their work appears in journals such as Nature, Journal of Biological Chemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.